AI-extracted claim
“Abbott Laboratories will pay nearly $385 million to settle claims of selling formula from facilities that did not meet safety requirements.”
Analyzed on 2026-09-19T09:40:11+00:00 · Last updated 2026-09-19
Plain language: Insufficient evidence was found to render a verdict.
Credibility score
out of 100
Based on 1 source
Low confidence
Original context
Show passage from source article
Abbott Laboratories, the maker of the popular infant formula Similac, will pay nearly $385 million to settle claims that it knowingly sold formula manufactured in facilities that did not meet safety requirements.
Extracted from: Abbott to Pay $385 Million to Settle Infant Formula Allegations , The New York Times
Evidence
This analysis is based on a single source. Confidence is low.
Bias distribution of supporting sources
Mean bias -0.20
Community Takes
No Takes have been written on this claim yet. Sign in to write a Take.